This cluster groups 2 independently calculated changes: Cash & equivalents changed across a low base; Operating cash flow increased 22.3%.
2 evidence-backed components· Pharmaceutical Preparations
RESEARCH SNAPSHOTIncannex Healthcare Inc.'s latest supported as-filed period reports revenue of $0. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents changed across a low base; Operating cash flow increased 22.3%.
2 evidence-backed componentsShares outstanding changed -59.4% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
Each point keeps the date investors could first observe it and its accession.
IXHL · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001213900-26-098213SEC ↗8-KAug 25, 2026Period Aug 25, 20260001213900-26-093244SEC ↗8-KAug 11, 2026Period Aug 11, 20260001213900-26-087493SEC ↗8-KJul 23, 2026Period Jul 23, 20260001213900-26-080622SEC ↗8-KJun 25, 2026Period Jun 25, 20260001213900-26-071745SEC ↗8-KJun 10, 2026Period Jun 10, 20260001213900-26-067081SEC ↗8-KJun 9, 2026Period Jun 9, 20260001213900-26-066526SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Nov 14, 2025Filed Nov 14, 2025 | Valentine TroyDirector | Grant Or AwardDirect | 11,302,608 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Operating income changed +19.1% from the comparable as-filed period.
Free-cash-flow proxy changed +22.1% from the comparable as-filed period.
Operating cash flow changed +22.3% from the comparable as-filed period.
Research & development changed -88.3% from the comparable as-filed period.
Current assets changed +412.5% from the comparable as-filed period.
Total assets changed +395.7% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-03-31. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001213900-26-057227